Hypogonadism and erectile dysfunction: pathophysiological observations and therapeutic outcomes

Area of Science:

• Endocrinology
• Urology
• Male Sexual Health

Background:

• Androgens significantly impact male sexual function and erectile physiology.
• Despite common beliefs, hypogonadal men can achieve erections, even during antiandrogen therapy.
• Restoring normal testosterone levels doesn't always fully recover libido and erectile function.

Purpose of the Study:

• To explore the complex relationship between androgens and male sexual function.
• To highlight that testosterone replacement therapy (TRT) has benefits beyond sexual health.
• To emphasize the importance of comprehensive assessment and management of hypogonadism.

Main Methods:

• Review of existing literature on androgen effects on male sexual function.
• Analysis of clinical observations regarding erections in hypogonadal and antiandrogen-treated men.
• Discussion of the multifaceted effects of testosterone replacement therapy.

Main Results:

• Erectile capacity exists even in the absence of normal androgen levels.
• Successful hormonal supplementation may not always restore sexual function completely.
• TRT positively impacts libido, well-being, bone density, muscle strength, and mental acuity.

Conclusions:

• Management of hypogonadism involves more than just restoring testosterone levels; it includes monitoring metabolites like dihydrotestosterone and oestradiol.
• Urologists play a crucial role in assessing, treating, and monitoring hypogonadism.
• Comprehensive TRT aims to maintain physiological levels of testosterone and its key metabolites for optimal outcomes.